Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear

Gene Therapy

Volumn 18, Issue 6, 2011, Pages 569-578

  Kilpatrick, L A ^a   Li, Q ^a   Yang, J ^a   Goddard, J C ^b   Fekete, D M ^c   Lang, H ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b HOUSE EAR INSTITUTE   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

AAV vectors; auditory nerves; hearing loss; scala media; sensory hair cells

Indexed keywords

ADENO ASSOCIATED VIRUS 1 VECTOR; ADENO ASSOCIATED VIRUS 2 VECTOR; ADENO ASSOCIATED VIRUS 5 VECTOR; ADENO ASSOCIATED VIRUS 6 VECTOR; ADENO ASSOCIATED VIRUS 8 VECTOR; GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCHLEA; COCHLEAR NERVE; CONTROLLED STUDY; CORTI ORGAN; CYTOMEGALOVIRUS; EVOKED BRAIN STEM AUDITORY RESPONSE; GENE EXPRESSION; HAIR CELL; HEARING IMPAIRMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE THERAPY;

ANIMALS; COCHLEAR DUCT; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HAIR CELLS, AUDITORY; HEARING LOSS; MICE; MICE, INBRED CBA; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; CYTOMEGALOVIRUS; EPITONIUM; MURINAE; MUS;

EID: 79958287787     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.175     Document Type: Article

References (62)

1. Roberson DW, Rubel EW. Cell division in the gerbil cochlea after acoustic trauma. Am J Otol 1994; 15: 28-34. (Pubitemid 24034513)
2. Yamashita H, Shimogori H, Sugahara K, Takahashi M. Cell proliferation in spiral ligament of mouse cochlea damaged by dihydrostreptomycin sulfate. Acta Otolaryngol 1999; 119: 322-325. (Pubitemid 29227396)
3. Lang H, Schulte BA, Schmiedt RA. Effects of chronic furosemide treatment and age on cell division in the adult gerbil inner ear. J Assoc Res Otolaryngol 2003; 4: 164-175. (Pubitemid 36753767)
4. Brignull HR, Raible DW, Stone JS. Feathers and fins: non-mammalian models for hair cell regeneration. Brain Res 2009; 1277: 12-23.
5. Groves AK. The challenge of hair cell regeneration. Exp Biol Med (Maywood) 2010; 235: 434-446.
6. Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, Dolan DF et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 2005; 11: 271-276. (Pubitemid 40460554)
7. Staecker H, Praetorius M, Baker K, Brough DE. Vestibular hair cell regeneration and restoration of balance function induced by math1 gene transfer. Otol Neurotol 2007; 28: 223-231. (Pubitemid 46175126)
8. Gubbels SP, Woessner DW, Mitchell JC, Ricci AJ, Brigande JV. Functional auditory hair cells produced in the mammalian cochlea by in utero gene transfer. Nature 2008; 455: 537-541.
9. Lalwani AK, Walsh BJ, Reilly PG, Muzyczka N, Mhatre AN. Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Therapy 1996; 3: 588-592. (Pubitemid 26258273)
10. Dazert S, Battaglia A, Ryan AF. Transfection of neo-natal rat cochlear cells in vitro with an adenovirus vector. Int J Dev Neurosci 1997; 15: 595-600. (Pubitemid 27332109)
11. Lalwani AK, Walsh BJ, Carvalho GJ, Muzyczka N, Mhatre AN. Expression of adenoassociated virus integrated transgene within the mammalian vestibular organs. Am J Otol 1998; 19: 390-395. (Pubitemid 28196827)
12. Kiernan AE, Fekete DM. In vivo gene transfer into the embryonic inner ear using retroviral vectors. Audiol Neurootol 1997; 2: 12-24. (Pubitemid 27083567)
13. Weiss MA, Frisancho JC, Roessler BJ, Raphael Y. Viral-mediated gene transfer in the cochlea. Int J Dev Neurosci 1997; 15: 577-583. (Pubitemid 27332107)
14. Lalwani A, Walsh B, Reilly P, Carvalho G, Zolotukhin S, Muzyczka N et al. Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Therapy 1998; 5: 277-281. (Pubitemid 28077757)
15. Derby ML, Sena-Esteves M, Breakefield XO, Corey DP. Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res 1999; 134: 1-8. (Pubitemid 29354511)
16. Holt JR, John DC, Wang S, Chen ZY, Dunn RI, Marban E et al. Functional expression of exogenous proteins in mammalian sensory hair cells infected with adenoviral vectors. J Neurophysiol 1999; 81: 1881-1888. (Pubitemid 29262519)
17. Van de Water TR, Staecker H, Halterman MW, Federoff HJ. Gene therapy in the inner ear. Mechanisms and clinical implications. Ann N Y Acad Sci 1999; 884: 345-360.
18. Yamasoba T, Yagi M, Roessler BJ, Miller JM, Raphael Y. Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac. Hum Gene Ther 1999; 10: 769-774. (Pubitemid 29168161)
19. Chen X, Frisina RD, Bowers WJ, Frisina DR, Federoff HJ. HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatininduced damage. Mol Ther 2001; 3: 958-963. (Pubitemid 32611305)
20. Jero J, Mhatre AN, Tsend CJ, Stern RE, Coling DE, Goldstein JA et al. Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther 2001; 12: 539-548. (Pubitemid 32511075)
21. Kawamoto K, Oh SH, Kanzaki S, Brown N, Raphael Y. The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice. Mol Ther 2001; 4: 575-585. (Pubitemid 34026873)
22. Staecker H, Li D, O'Malley Jr BW, Van de Water TR. Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolarngol 2001; 121: 157-163. (Pubitemid 32328558)
23. Luebke AE, Foster PK, Muller CD, Peel AL. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Hum Gene Ther 2001; 12: 773-781. (Pubitemid 32692343)
24. Ishimoto S, Kawamoto K, Kanzaki S, Raphael Y. Gene transfer into supporting cells of the organ of Corti. Hear Res 2002; 173: 187-197.
25. Liu Y, Okada T, Sheykholeslami K, Shimazaki K, Nomoto T, Muramatsu S et al. Specific and efficient transduction of cochlear inner hair cells with recombinant adenoassociated virus type 3 vector. Mol Ther 2005; 12: 725-733. (Pubitemid 41350154)
26. Stone IM, Lurie DI, Kelley MW, Poulsen DJ. Adeno-associated virus-mediated gene transfer to hair cells and support cells of the murine cochlea. Mol Ther 2005; 11: 843-848. (Pubitemid 40724102)
27. Bedrosian JC, Gratton MA, Brigande JV, Tang W, Landau J et al. In vivo delivery of recombinant viruses to the fetal murine cochlea: transduction characteristics and longterm effects on auditory function. Mol Ther 2006; 14: 328-335. (Pubitemid 44184963)
28. Cooper LB, Chan DK, Roediger FC, Shaffer BR, Fraser JF, Musatov S et al. AAVmediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity. Otol Neurotol 2006; 27: 484-490.
29. Kesser BW, Hashisaki GT, Fletcher K, Eppard H, Holt JR. An in vitro model system to study gene therapy in the human inner ear. Gene Therapy 2007; 14: 1121-1131. (Pubitemid 47086742)
30. Venail F, Wang J, Ruel J, Ballana E, Rebillard G, Eybalin M et al. Coxsackie adenovirus receptor and alpha nu beta3/alpha nu beta5 integrins in adenovirus gene transfer of rat cochlea. Gene Therapy 2007; 14: 30-37. (Pubitemid 44942863)
31. Wenzel GI, Xia A, Funk E, Evans MB, Palmer DJ, Ng P et al. Helper-dependent adenovirus-mediated gene transfer into the adult mouse cochlea. Otol Neurotol 2007; 28: 1100-1108. (Pubitemid 350191086)
32. Iizuka T, Kanzaki S, Mochizuki H, Inoshita A, Narui Y, Furukawa M et al. Noninvasive in vivo delivery of transgene via adeno-associated virus into supporting cells of the neonatal mouse cochlea. Hum Gene Ther 2008; 19: 384-390. (Pubitemid 351591431)
33. Luebke A, Rova C, Doersten P, Poulsen D. Adenoviral and AAV-Mediated gene transfer to the inner ear: role of serotype, promoter, and viral load on in vivo and in vitro infection efficiencies. In: Ryan A (ed). Gene Therapy of Cochlear Deafness, vol. 66, Karger: Basel, 2009, pp 87-98.
34. Kesser B, Lalwani A. Gene therapy and stem cell transplantation: strategies for hearing restoration. In: Ryan A (ed). Gene Therapy of Cochlear Deafness, vol. 66, Karger: Basel, 2009, pp 64-86.
35. Husseman J, Raphael Y. Gene therapy in the inner ear using adenovirus vectors. In: Ryan A (ed). Gene Therapy of Cochlear Deafness, vol. 66, Karger: Basel, 2009, pp 37-51.
36. Ryan A, Mullen L, Doherty J. Cellular targeting for cochlear gene therapy. In: Ryan A (ed). Gene Therapy of Cochlear Deafness, vol. 66, Karger: Basel, 2009, pp 99-115.
37. Shibata SB, Di Pasquale G, Cortez SR, Chiorini JA, Raphael Y. Gene transfer using bovine adeno-associated virus in the guinea pig cochlea. Gene Therapy 2009; 16: 990-997.
38. Hankenson FC, Wathen AB, Eaton KA, Miyazawa T, Swiderski DL, Raphael Y. Guinea pig adenovirus infection does not inhibit cochlear transfection with human adenoviral vectors in a model of hearing loss. Comp Med 2010; 60: 130-135.
39. Praetorius M, Brough DE, Hsu C, Plinkert PK, Pfannenstiel SC, Staecker H. Adenoviral vectors for improved gene delivery to the inner ear. Hear Res 2009; 248: 31-38.
40. Praetorius M, Hsu C, Baker K, Brough DE, Plinkert P, Staecker H. Adenovectormediated hair cell regeneration is affected by promoter type. Acta Otolaryngol 2010; 130: 215-222.
41. Taura A, Taura K, Choung YH, Masuda M, Pak K, Chavez E et al. Histone deacetylase inhibition enhances adenoviral vector transduction in inner ear tissue. Neuroscience 2010; 66: 1185-1193.
42. Luebke AE, Steiger JD, Hodges BL, Amalfitano A. A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function. Gene Therapy 2001; 8: 789-794. (Pubitemid 32509793)
43. Liu Y, Okada T, Nomoto T, Ke X, Kume A, Ozawa K et al. Promoter effects of adenoassociated viral vector for transgene expression in the cochlea in vivo. Exp Mol Med 2007; 39: 170-175. (Pubitemid 46683402)
44. Oesterle EC, Campbell S, Taylor RR, Forge A, Hume CR. Sox2 and Jagged1 expression in normal and drug-damaged adult mouse inner ear. J Assoc Res Otolaryngol 2008; 9: 65-89.
45. Taylor RR, Nevill G, Forge A. Rapid hair cell loss: a mouse model for cochlear lesions. J Assoc Res Otolaryngol 2008; 9: 44-64.
46. Oesterle EC, Campbell S. Supporting cell characteristics in long-deafened aged mouse ears. J Assoc Res Otolaryngol 2009; 10: 525-544.
47. Thorne M, Salt AN, DeMott JE, Henson MM, Henson Jr OW, Gewalt SL. Cochlear fluid space dimensions for six species derived from reconstructions of three-dimensional magnetic resonance images. Laryngoscope 1999; 109: 1661-1668. (Pubitemid 29477235)
48. Chen Z, Mikulec AA, McKenna MJ, Sewell WF, Kujawa SG. A method for intracochlear drug delivery in the mouse. Neurosci Methods 2006; 150: 67-73. (Pubitemid 41770799)
49. Borkholder DA, Zhu X, Hyatt BT, Archilla AS, Livingston WJ, Frisina RD. Murine intracochlear drug delivery: reducing concentration gradients within the cochlea. Hear Res 2010; 268: 2-11.
50. Lang H, Schulte BA, Schmiedt RA. Endocochlear potentials and compound action potential recovery functions in the C57BL/6J mouse. Hear Res 2002; 172: 118-126. (Pubitemid 35299961)
51. Hester ME, Foust KD, Kaspar RW, Kaspar BK. AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALS. Curr Gene Ther 2009; 9: 428-433.
52. Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-1445. (Pubitemid 28116931)
53. Summerford C, Bartlett JS, Samulski RJ. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 1999; 5: 78-82. (Pubitemid 29051002)
54. Akache B, Grimm D, Pandey K, Yant SR, Xu H, Kay MA. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J Virol 2006; 80: 9831-9836. (Pubitemid 44435657)
55. Negishi A, Chen J, McCarty DM, Samulski RJ, Liu J, Superfine R. Analysis of the interaction between adeno-associated virus and heparan sulfate using atomic force microscopy. Glycobiology 2004; 14: 969-977. (Pubitemid 39430029)
56. Spicer SS, Schulte BA. The fine structure of spiral ligament cells relates to ion return to the stria and varies with place-frequency. Hear Res 1996; 100: 80-100. (Pubitemid 26359766)
57. Steel KP. Perspectives: biomedicine. The benefits of recycling. Science 1999; 285: 1363-1364.
58. Minowa O, Ikeda K, Sugitani Y, Oshima T, Nakai S, Katori Y et al. Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science 1999; 285: 1408-1411. (Pubitemid 29411674)
59. Shibata SB, Cortez SR, Beyer LA, Wiler JA, Di Polo A, Pfingst BE et al. Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp Neurol 2010; 223: 464-472.
60. Auricchio A, O'Connor E, Hildinger M, Wilson JM. A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors. Mol Ther 2001; 4: 372-374. (Pubitemid 33040523)
61. Lang H, Schulte BA, Zhou D, Smythe N, Spicer SS, Schmiedt RA. Nuclear factor kappaB deficiency is associated with auditory nerve degeneration and increased noiseinduced hearing loss. J Neurosci 2006; 26: 3541-3550.
62. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC. Green fluorescent protein as a marker for gene expression. Science 1994; 263: 802-805. (Pubitemid 24093206)